Floridi A, Pulselli R, Gentile F P, Barbieri R, Benassi M
Laboratory of Cell Metabolism and Pharmacokinetics, Regina Elena Institute for Cancer Research, Rome, Italy.
Biochem Pharmacol. 1994 May 18;47(10):1781-8. doi: 10.1016/0006-2952(94)90306-9.
The effect of the combination of Adriamycin (ADM) with rhein (RH), an anti-inflammatory drug, on the electron flow through site III and IV of the respiratory chain of rat liver mitochondria was investigated. RH, even at high concentrations, does not inhibit either duroquinol (DHQ) oxidation or cytochrome oxidase activity both of which are decreased by ADM in a dose-dependent manner. The analysis of interaction, performed with the isobolar method, shows a strong synergistic effect that cannot be ascribed to increased permeability of the mitochondrial membranes brought about by RH. The mechanism by which RH potentiates the effect of ADM on DHQ oxidation and cytochrome oxidase activity is most likely to be changes induced in the physical status of the inner mitochondrial membrane such as to permit low ADM concentrations to bind and segregate enough cardiolipin to inhibit electron transport through complex III and IV.
研究了抗炎药物大黄酸(RH)与阿霉素(ADM)联合使用对大鼠肝线粒体呼吸链位点III和IV电子流的影响。即使在高浓度下,RH也不会抑制抗霉素(DHQ)氧化或细胞色素氧化酶活性,而这两种活性都会被ADM以剂量依赖的方式降低。用等效线法进行的相互作用分析显示出强烈的协同作用,这不能归因于RH引起的线粒体膜通透性增加。RH增强ADM对DHQ氧化和细胞色素氧化酶活性影响的机制很可能是线粒体内膜物理状态发生变化,从而使低浓度的ADM能够结合并分离足够的心磷脂,以抑制通过复合物III和IV的电子传递。